Cardinal Health Inc (CAH) Stock Price Today
Vertex Pharmaceuticals rises on strong cystic fibrosis sales and promising kidney drug trials, UBS hikes price target.
Vertex Pharmaceuticals reported a 12% revenue increase to $3.33 billion in Q2, driven by its dominant cystic fibrosis treatments. UBS raised its price target from $585 to $615, reflecting confidence in Vertex's strong financials and growth potential....
SpaceX nears Starship's first orbital launch and Starlink V3 deployment, boosting investor optimism.
SpaceX, trading near $148 per share with a market cap of about $1.95 trillion, is preparing for Starship's first orbital mission and the deployment of its first operational Starlink V3 satellites. This milestone is key for expanding Starlink's global...
10x Genomics gets Buy rating despite insider selling and valuation concerns.
Argus Research initiated coverage on 10x Genomics with a Buy rating and a $110 price target, suggesting a 28% upside from its current price of around $85. The stock shows strong momentum, trading well above its 50-day and 200-day moving averages. How...
Rising yields and inflation fears push fintech stocks SoFi, Affirm, and Robinhood down.
Fintech stocks SoFi, Affirm, and Robinhood fell by 3%, 4%, and 2% respectively due to rising Treasury yields and inflation concerns driven by higher oil prices and geopolitical tensions. These factors raise fears of further Federal Reserve rate hikes...
Corteva and Inari settle 2023 seed patent lawsuit with confidential terms and licensing talks.
Corteva and Inari have reached a confidential settlement to resolve a 2023 lawsuit over seed patent issues. Inari agreed to destroy certain Corteva materials and assign related intellectual property back to Corteva. Both companies will negotiate lice...
NeuroSense CFO to discuss ALS drug PrimeC progress at ROTH Healthcare Conference
NeuroSense Therapeutics CFO Or Eisenberg will participate in the 5th Annual ROTH Healthcare Opportunities Conference on September 29, 2026, in New York City. He will hold meetings with institutional investors to discuss the company's recent clinical ...
Hormel remains a hold as inflation and cost pressures slow its dividend growth despite strong yield.
Hormel (HRL), a U.S.-based protein food company, is rated a 'hold' due to ongoing inflation, input cost pressures, and weak organic growth offsetting its undervaluation and strong dividend history. New management has streamlined operations, exiting l...
Mesabi Metallics to invest $15B in largest US steel plant, creating 1,750 jobs by 2030
Mesabi Metallics plans to invest about $15 billion to build the largest steel plant in U.S. history in Iowa, aiming to start production by 2030. The project is expected to create around 1,750 permanent jobs and up to 6,000 construction jobs initially...
Lifecore shareholders question $6.28 per share deal as Ademi LLP probes fairness and board actions
Lifecore shareholders are set to receive $6.28 per share in a $663.7 million acquisition by Webster Equity Partners. Ademi LLP is investigating whether this price fairly reflects Lifecore's value and future prospects, and is scrutinizing benefits to ...
Microsoft leads in AI capex efficiency with positive cash flow; Alphabet grows faster but faces cash flow challenges.
Microsoft and Alphabet are investing heavily in AI data centers, but their monetization strategies differ significantly. Microsoft posted 17.8% revenue growth and positive free cash flow of $19.64 billion on $35.80 billion capex, driven by Azure's 43...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.